Organism name | Solanum lycopersicum L. |
---|---|
Genus | Solanum |
Family | Solanaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Solanum lycopersicum |
---|---|
Linked NCBI taxonomy ID | 4081 |
Linked level | species |
Family in NCBI taxonomy | Solanaceae |
---|---|
ID | 4070 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00001140
![]() |
Maltose
|
CHEMBL417016
CHEMBL469865 CHEMBL470274 CHEMBL1254686 CHEMBL1903530 CHEMBL1908365 |
D008320
|
6 / 0 / 1 | 2 / 0 | No. 423 | No. 73 |
![]() |
C00001152
![]() |
Trehalose
|
D014199
|
No. 423 | No. 73 |
![]() |
|||
C00001434
![]() |
Tryptamine
/ beta-(3-Indolyl)ethylamine |
CHEMBL6640
|
C030820
|
20 / 5 / 7 | 6 / 2 | No. 710 | No. 4 |
![]() |
C00001164
![]() |
Myoinositol
/ myo-Inositol |
CHEMBL278373
CHEMBL468154 CHEMBL1222251 CHEMBL1231671 CHEMBL1950780 |
8 / 17 / 18 | No. 795 |
![]() |
|||
C00001435
![]() |
Tyramine
|
CHEMBL11608
|
D014439
|
23 / 11 / 6 | 6 / 9 | No. 936 | No. 6 |
![]() |
C00001408
![]() |
Dopamine
|
CHEMBL59
|
D004298
|
69 / 40 / 56 | 51 / 52 | No. 1114 | No. 6 |
![]() |
C00034198
![]() |
Ribose
/ D-Ribose |
D012266
|
1 / 0 | No. 1384 |
![]() |
|||
C00019681
![]() |
Galactose
/ D-Galactose / D-(+)-Galactose |
CHEMBL1206211
|
No. 1384 |
![]() |
||||
C00035100
![]() |
Fucose
/ L-(-)-Fucose |
No. 1384 |
![]() |
|||||
C00033848
![]() |
Fructose
/ D-Fructose / D-(-)-Fructose |
CHEMBL23894
CHEMBL1869413 |
9 / 4 / 3 | No. 1614 |
![]() |
|||
C00001161
![]() |
Erythritol
/ meso-Erythritol |
CHEMBL349605
CHEMBL402812 |
D004896
|
3 / 5 / 5 | No. 2923 |
![]() |
||
C00001428
![]() |
Putrescine
|
CHEMBL46257
|
D011700
|
9 / 5 / 4 | 3 / 4 | No. 3767 |
![]() |
|
C00001361
![]() |
Glycine
|
CHEMBL773
|
95 / 37 / 32 | No. 3932 |
![]() |
|||
C00001151
![]() |
Sucrose
/ (+)-Sucrose |
CHEMBL253582
CHEMBL1976550 |
D013395
|
1 / 0 / 0 | 4 / 10 | No. 3949 |
![]() |
|
C00001431
![]() |
Spermidine
|
CHEMBL19612
|
D013095
|
26 / 10 / 12 | 5 / 5 | No. 5867 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00001361 C00001408 C00001428 C00001431 C00001434 C00001435 | 1 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00001361 C00001408 C00001428 C00001431 C00001434 C00001435 | 0 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00001361 C00001408 C00001428 C00001431 C00001434 C00001435 | 0 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00001361 C00001408 C00001428 C00001431 C00001434 C00001435 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00001361 C00001408 C00001428 C00001431 C00001434 C00001435 | 1 / 1 |
P00918 | Carbonic anhydrase 2 | Lyase | C00001161 C00001361 C00001408 C00001431 | 1 / 2 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001361 C00001408 C00001434 C00001435 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00001164 C00001434 C00001435 C00033848 | 0 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00001428 C00001435 C00033848 | 2 / 0 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00001161 C00001408 C00001431 | 0 / 1 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00001361 C00001408 C00001435 | 0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00001408 C00001435 C00033848 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00001408 C00001431 C00001435 | 0 / 0 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00001361 C00001408 C00001435 | 2 / 0 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00001361 C00001408 | 0 / 0 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00001361 C00001408 | 1 / 1 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00001434 C00033848 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00001164 C00001408 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00001361 C00001408 | 0 / 0 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00001408 C00001431 | 0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00001408 C00001431 | 0 / 0 |
P43166 | Carbonic anhydrase 7 | Lyase | C00001408 C00001431 | 0 / 0 |
P07451 | Carbonic anhydrase 3 | Lyase | C00001408 C00001431 | 0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00001408 C00001431 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00001428 C00001434 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001361 C00001434 | 0 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00001361 C00001434 | 0 / 0 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00001361 C00001408 | 1 / 0 |
P22748 | Carbonic anhydrase 4 | Lyase | C00001408 C00001431 | 1 / 1 |
O15245 | Solute carrier family 22 member 1 | Drug uniporter | C00001408 C00001435 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00001408 C00033848 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00001408 C00001435 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00001361 C00001408 | 0 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00001361 C00001434 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00001361 C00001408 | 2 / 0 |
P40225 | Thrombopoietin | Unclassified protein | C00001408 C00001431 | 1 / 1 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00001361 C00001408 | 0 / 1 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00001361 C00001435 | 1 / 1 |
P14679 | Tyrosinase | Oxidoreductase | C00001408 C00001435 | 4 / 2 |
P00915 | Carbonic anhydrase 1 | Lyase | C00001408 C00001431 | 0 / 0 |
P46098 | 5-hydroxytryptamine receptor 3A | NS | C00001361 C00001435 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00001361 C00001408 | 1 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00001361 C00001408 | 1 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00001361 C00001408 | 0 / 0 |
Q9H015 | Solute carrier family 22 member 4 | Unclassified protein | C00001428 C00001431 | 1 / 1 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00001361 C00001408 | 0 / 0 |
P10323 | Acrosin | S1A | C00001164 C00033848 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00001408 C00033848 | 0 / 0 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00001361 C00001434 | 0 / 0 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00001361 C00001408 | 0 / 0 |
O43570 | Carbonic anhydrase 12 | Lyase | C00001408 C00001431 | 1 / 2 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00001408 C00001435 | 0 / 0 |
P42345 | Serine/threonine-protein kinase mTOR | Enzyme | C00001408 C00001431 | 0 / 0 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00001408 C00001431 | 0 / 0 |
P23280 | Carbonic anhydrase 6 | Lyase | C00001408 C00001431 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00001431 C00001434 | 0 / 0 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00001361 | 0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00001361 | 1 / 8 |
P11473 | Vitamin D3 receptor | NR1I1 | C00033848 | 2 / 3 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00001434 | 1 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00001361 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00001361 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00001361 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00001361 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00001361 | 0 / 0 |
P09382 | Galectin-1 | Other cytosolic protein | C00001140 | 0 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00001361 | 0 / 0 |
P05164 | Myeloperoxidase | Enzyme | C00001434 | 1 / 2 |
P43235 | Cathepsin K | C1A | C00001434 | 1 / 2 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00001361 | 1 / 1 |
O15296 | Arachidonate 15-lipoxygenase B | Enzyme | C00001431 | 0 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00001361 | 0 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00001361 | 1 / 0 |
P16662 | UDP-glucuronosyltransferase 2B7 | Enzyme | C00001408 | 0 / 0 |
O95622 | Adenylate cyclase type 5 | Enzyme | C00001408 | 1 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00001361 | 0 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00001361 | 0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00001408 | 0 / 0 |
P02768 | Serum albumin | Secreted protein | C00001151 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00001431 | 0 / 0 |
O00214 | Galectin-8 | Unclassified protein | C00001140 | 0 / 0 |
P16278 | Beta-galactosidase | Enzyme | C00001164 | 4 / 6 |
P50225 | Sulfotransferase 1A1 | Enzyme | C00001408 | 0 / 0 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | C00001408 | 0 / 0 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00001361 | 0 / 0 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00001361 | 0 / 0 |
P21918 | D(1B) dopamine receptor | Dopamine receptor | C00001408 | 1 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00001361 | 0 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00001361 | 0 / 0 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00001361 | 0 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00001361 | 0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00001361 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00001361 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00001361 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00001361 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00001361 | 1 / 0 |
P28222 | 5-hydroxytryptamine receptor 1B | Serotonin receptor | C00001434 | 0 / 0 |
Q6QHF9 | Peroxisomal N(1)-acetyl-spermine/spermidine oxidase | Enzyme | C00001431 | 0 / 0 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00001361 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00001361 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00001361 | 1 / 0 |
P03956 | Interstitial collagenase | M10A | C00001361 | 0 / 1 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00001361 | 0 / 0 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00001435 | 0 / 0 |
P50224 | Sulfotransferase 1A3/1A4 | Enzyme | C00001408 | 0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | C00001361 | 0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00001361 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00001361 | 0 / 0 |
P25021 | Histamine H2 receptor | Histamine receptor | C00001361 | 0 / 0 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00001361 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00001431 | 3 / 2 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00001361 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00001361 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00001361 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00001361 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00001361 | 3 / 0 |
P37840 | Alpha-synuclein | Unclassified protein | C00001161 | 4 / 2 |
P36544 | Neuronal acetylcholine receptor subunit alpha-7 | CHRN alpha | C00001361 | 0 / 0 |
P06280 | Alpha-galactosidase A | Enzyme | C00001164 | 1 / 1 |
P48039 | Melatonin receptor type 1A | Melatonin receptor | C00001408 | 0 / 0 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00001361 | 1 / 0 |
P23415 | Glycine receptor subunit alpha-1 | GLR alpha | C00001361 | 1 / 1 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00001361 | 2 / 1 |
P56817 | Beta-secretase 1 | A1A | C00001435 | 0 / 0 |
O43704 | Sulfotransferase family cytosolic 1B member 1 | Enzyme | C00001408 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00001164 | 11 / 10 |
Q16853 | Membrane primary amine oxidase | Enzyme | C00001408 | 0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00001408 | 3 / 3 |
P47929 | Galectin-7 | Unclassified protein | C00001140 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00001361 | 0 / 0 |
P03372 | Estrogen receptor | NR3A1 | C00001361 | 1 / 1 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00033848 | 0 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00001361 | 1 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00001361 | 2 / 2 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00001361 | 0 / 0 |
Q9HAW7 | UDP-glucuronosyltransferase 1-7 | Enzyme | C00001408 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00001361 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00001361 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00001361 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00001361 | 0 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00001361 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00001361 | 0 / 0 |
P49286 | Melatonin receptor type 1B | Melatonin receptor | C00001408 | 0 / 1 |
P46059 | Solute carrier family 15 member 1 | Dipeptide | C00001361 | 0 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00001361 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00001361 | 0 / 0 |
Q96RJ0 | Trace amine-associated receptor 1 | Trace amine receptor | C00001435 | 0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00001361 | 0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00001408 | 0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00001408 | 5 / 1 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00001408 | 4 / 3 |
Q99549 | M-phase phosphoprotein 8 | Unclassified protein | C00001408 | 0 / 0 |
Q7Z2H8 | Proton-coupled amino acid transporter 1 | Unclassified protein | C00001361 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00001434 | 0 / 0 |
O43451 | Maltase-glucoamylase, intestinal | Hydrolase | C00001164 | 0 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00001361 | 0 / 0 |
P08246 | Neutrophil elastase | S1A | C00001361 | 2 / 1 |
P28221 | 5-hydroxytryptamine receptor 1D | Serotonin receptor | C00001434 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00001361 | 0 / 0 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00001361 | 2 / 2 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00001361 | 1 / 1 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00001361 | 0 / 3 |
P06239 | Tyrosine-protein kinase Lck | Src | C00001361 | 0 / 1 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00001361 | 0 / 0 |
Q6P4F1 | Alpha-(1,3)-fucosyltransferase 10 | Enzyme | C00001140 | 0 / 0 |
P27338 | Amine oxidase [flavin-containing] B | Oxidoreductase | C00001435 | 0 / 0 |
P17931 | Galectin-3 | Other cytosolic protein | C00001140 | 0 / 1 |
Q99700 | Ataxin-2 | Unclassified protein | C00001408 | 1 / 1 |
O00182 | Galectin-9 | Unclassified protein | C00001140 | 0 / 0 |
Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | C00001408 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00001408 | 0 / 0 |
O15244 | Solute carrier family 22 member 2 | Drug uniporter | C00001408 | 0 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00001408 | 7 / 37 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00001408 | 1 / 1 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00001408 | 3 / 0 |
O75751 | Solute carrier family 22 member 3 | Unclassified protein | C00001435 | 0 / 0 |
Q05BR4 | SLC16A10 protein | Unclassified protein | C00001361 | 0 / 0 |
P35368 | Alpha-1B adrenergic receptor | Adrenergic receptor | C00001408 | 0 / 0 |
P35348 | Alpha-1A adrenergic receptor | Adrenergic receptor | C00001408 | 0 / 0 |
P17707 | S-adenosylmethionine decarboxylase proenzyme | Enzyme | C00001428 | 0 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00001164 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
6530 | SLC6A2, NAT1, NET, NET1, SLC6A5 | solute carrier family 6 (neurotransmitter transporter), member 2 |
C00001408
C00001434
C00001435
|
134864 | TAAR1, RP11-295F4.9, TA1, TAR1, TRAR1 | trace amine associated receptor 1 |
C00001408
C00001434
C00001435
|
6531 | SLC6A3, DAT, DAT1, PKDYS | solute carrier family 6 (neurotransmitter transporter), member 3 |
C00001408
C00001434
C00001435
|
6532 | SLC6A4, 5-HTT, 5-HTTLPR, 5HTT, HTT, OCD1, SERT, SERT1, hSERT | solute carrier family 6 (neurotransmitter transporter), member 4 |
C00001408
C00001434
C00001435
|
153 | ADRB1, ADRB1R, B1AR, BETA1AR, RHR | adrenoceptor beta 1 |
C00001428
C00001431
|
154 | ADRB2, ADRB2R, ADRBR, B2AR, BAR, BETA2AR | adrenoceptor beta 2, surface |
C00001428
C00001431
|
6818 | SULT1A3, HAST, HAST3, M-PST, ST1A3/ST1A4, ST1A5, STM, TL-PST | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 (EC:2.8.2.1) |
C00001408
C00001435
|
3630 | INS, IDDM2, ILPR, IRDN, MODY10 | insulin |
C00001151
C00001408
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00001408
C00001431
|
6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00001408
|
664 | BNIP3, NIP3 | BCL2/adenovirus E1B 19kDa interacting protein 3 |
C00001408
|
27113 | BBC3, JFY-1, JFY1, PUMA | BCL2 binding component 3 |
C00001408
|
840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00001408
|
847 | CAT | catalase (EC:1.11.1.6) |
C00001408
|
1312 | COMT | catechol-O-methyltransferase (EC:2.1.1.6) |
C00001408
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00001408
|
1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
C00001408
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00001408
|
1812 | DRD1, DADR, DRD1A | dopamine receptor D1 |
C00001408
|
1813 | DRD2, D2DR, D2R | dopamine receptor D2 |
C00001408
|
2152 | F3, CD142, TF, TFA | coagulation factor III (thromboplastin, tissue factor) |
C00001408
|
2353 | FOS, AP-1, C-FOS, p55 | FBJ murine osteosarcoma viral oncogene homolog |
C00001408
|
2668 | GDNF, ATF1, ATF2, HFB1-GDNF, HSCR3 | glial cell derived neurotrophic factor |
C00001408
|
2938 | GSTA1, GST2, GSTA1-1, GTH1 | glutathione S-transferase alpha 1 (EC:2.5.1.18) |
C00001408
|
2944 | GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MU, MU-1 | glutathione S-transferase mu 1 (EC:2.5.1.18) |
C00001408
|
2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00001408
|
3091 | HIF1A, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1, PASD8, bHLHe78 | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
C00001408
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00001408
|
3359 | HTR3A, 5-HT-3, 5-HT3A, 5-HT3R, 5HT3R, HTR3 | 5-hydroxytryptamine (serotonin) receptor 3A, ionotropic |
C00001408
|
9177 | HTR3B, 5-HT3B | 5-hydroxytryptamine (serotonin) receptor 3B, ionotropic |
C00001408
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00001408
|
3725 | JUN, AP-1, AP1, c-Jun | jun proto-oncogene |
C00001408
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00001408
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00001408
|
4137 | MAPT, DDPAC, FTDP-17, MAPTL, MSTD, MTBT1, MTBT2, PPND, TAU | microtubule-associated protein tau |
C00001408
|
2475 | MTOR, FRAP, FRAP1, FRAP2, RAFT1, RAPT1 | mechanistic target of rapamycin (serine/threonine kinase) (EC:2.7.11.1) |
C00001408
|
4548 | MTR, HMAG, MS, cblG | 5-methyltetrahydrofolate-homocysteine methyltransferase (EC:2.1.1.13) |
C00001408
|
5071 | PARK2, AR-JP, LPRS2, PDJ, PRKN | parkin RBR E3 ubiquitin protein ligase |
C00001408
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00001408
|
5617 | PRL | prolactin |
C00001408
|
5998 | RGS3, C2PA, RGP3 | regulator of G-protein signaling 3 |
C00001408
|
6198 | RPS6KB1, PS6K, S6K, S6K-beta-1, S6K1, STK14A, p70_S6KA, p70(S6K)-alpha, p70-S6K, p70-alpha | ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) |
C00001408
|
6343 | SCT | secretin |
C00001408
|
6570 | SLC18A1, CGAT, VAT1, VMAT1 | solute carrier family 18 (vesicular monoamine transporter), member 1 |
C00001408
|
6571 | SLC18A2, SVAT, SVMT, VAT2, VMAT2 | solute carrier family 18 (vesicular monoamine transporter), member 2 |
C00001408
|
85413 | SLC22A16, CT2, FLIPT2, OAT6, OCT6, OKB1, dJ261K5.1 | solute carrier family 22 (organic cation/carnitine transporter), member 16 |
C00001408
|
9016 | SLC25A14, BMCP1, UCP5 | solute carrier family 25 (mitochondrial carrier, brain), member 14 |
C00001408
|
6622 | SNCA, NACP, PARK1, PARK4, PD1 | synuclein, alpha (non A4 component of amyloid precursor) |
C00001408
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00001408
|
183 | AGT, ANHU, SERPINA8 | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
C00001408
|
7054 | TH, DYT14, DYT5b, TYH | tyrosine hydroxylase (EC:1.14.16.2) |
C00001408
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00001408
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00001408
|
6514 | SLC2A2, GLUT2 | solute carrier family 2 (facilitated glucose transporter), member 2 |
C00001140
|
6515 | SLC2A3, GLUT3 | solute carrier family 2 (facilitated glucose transporter), member 3 |
C00001140
|
1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) |
C00001434
|
3356 | HTR2A, 5-HT2A, HTR2 | 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
C00001434
|
26 | AOC1, ABP, ABP1, DAO, DAO1, KAO | amine oxidase, copper containing 1 (EC:1.4.3.22) |
C00001428
|
567 | B2M | beta-2-microglobulin |
C00034198
|
486 | FXYD2, ATP1G1, HOMG2 | FXYD domain containing ion transport regulator 2 |
C00001431
|
331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00001431
|
55630 | SLC39A4, AEZ, AWMS2, ZIP4 | solute carrier family 39 (zinc transporter), member 4 |
C00001151
|
80834 | TAS1R2, GPR71, T1R2, TR2 | taste receptor, type 1, member 2 |
C00001151
|
83756 | TAS1R3, T1R3 | taste receptor, type 1, member 3 |
C00001151
|
4128 | MAOA, MAO-A | monoamine oxidase A (EC:1.4.3.4) |
C00001435
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#606798 | Blepharospasm, benign essential |
P21918
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#162800 | Cyclic neutropenia |
P08246
|
#127750 | Dementia, lewy body; dlb |
P37840
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#606703 | Dyskinesia, familial, with facial myokymia; fdfm |
O95622
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#301500 | Fabry disease |
P06280
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137800 | Glioma susceptibility 1; glm1 |
P04626
|
#230500 | Gm1-gangliosidosis, type i |
P16278
|
#230600 | Gm1-gangliosidosis, type ii |
P16278
|
#230650 | Gm1-gangliosidosis, type iii |
P16278
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#149400 | Hyperekplexia, hereditary 1; hkpx1 |
P23415
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#253010 | Mucopolysaccharidosis type ivb |
P16278
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#254600 | Myeloperoxidase deficiency; mpod |
P05164
|
#159900 | Myoclonic dystonia |
P14416
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168601 | Parkinson disease 1, autosomal dominant; park1 |
P37840
|
#605543 | Parkinson disease 4, autosomal dominant; park4 |
P37840
|
#168600 | Parkinson disease, late-onset; pd |
P37840
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#172700 | Pick disease of brain |
P10636
|
#265800 | Pycnodysostosis |
P43235
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#180300 | Rheumatoid arthritis; ra |
Q9H015
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#610379 | West nile virus, susceptibility to |
P51681
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) Q16790 (marker) |
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P17931 (marker) |
H00033 | Adrenal carcinoma |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00101 | Other phagocyte defects |
P05164
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P05164
(marker)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00123 | Mucopolysaccharidosis type IV (MPS4) |
P16278
(related)
|
H00276 | Galactosialidosis |
P16278
(related)
|
H00281 | GM1 gangliosidosis |
P16278
(related)
|
H00421 | Mucopolysaccharidosis (MPS) |
P16278
(related)
|
H00422 | Glycoproteinoses |
P16278
(related)
|
H00426 | Defects in the degradation of ganglioside |
P16278
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H00769 | Hyperekplexia |
P23415
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00057 | Parkinson's disease (PD) |
P37840
(related)
|
H00066 | Lewy body dementia (LBD) |
P37840
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00273 | Pycnodysostosis |
P43235
(related)
|
H00425 | Lysosomal cysteine protease deficiencies |
P43235
(related)
|
H00409 | Type II diabetes mellitus |
P49286
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
Q9NUW8 (related) |
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00286 | Crohn's disease |
Q9H015
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D006973 | Hypertension |
C00001408
C00001428 C00001151 C00001435 |
D012640 | Seizures |
C00001434
C00001408 C00001431 |
D006948 | Hyperkinesis |
C00001408
C00001431 C00001151 |
D056486 | Drug-Induced Liver Injury |
C00001428
C00001431 |
D011041 | Poisoning |
C00001431
C00001435 |
D013610 | Tachycardia |
C00001408
C00001435 |
D007022 | Hypotension |
C00001408
C00001435 |
D014202 | Tremor |
C00001434
C00001408 |
D006332 | Cardiomegaly |
C00001428
C00001431 |
D018487 | Ventricular Dysfunction, Left |
C00001408
|
D019970 | Cocaine-Related Disorders |
C00001408
|
D004342 | Drug Hypersensitivity |
C00001408
|
D062787 | Drug Overdose |
C00001408
|
D004409 | Dyskinesia, Drug-Induced |
C00001408
|
D004417 | Dyspnea |
C00001408
|
D004802 | Eosinophilia |
C00001408
|
D006323 | Heart Arrest |
C00001408
|
D006331 | Heart Diseases |
C00001408
|
D006333 | Heart Failure |
C00001408
|
D006556 | Heroin Dependence |
C00001408
|
D006930 | Hyperalgesia |
C00001408
|
D002389 | Catatonia |
C00001408
|
D002375 | Catalepsy |
C00001408
|
D007008 | Hypokalemia |
C00001408
|
D018476 | Hypokinesia |
C00001408
|
D002303 | Cardiac Output, Low |
C00001408
|
D007024 | Hypotension, Orthostatic |
C00001408
|
D007859 | Learning Disorders |
C00001408
|
D008133 | Long QT Syndrome |
C00001408
|
D020149 | Manganese Poisoning |
C00001408
|
D048629 | Micronuclei, Chromosome-Defective |
C00001408
|
D017202 | Myocardial Ischemia |
C00001408
|
D009205 | Myocarditis |
C00001408
|
D009336 | Necrosis |
C00001408
|
D009410 | Nerve Degeneration |
C00001408
|
D009422 | Nervous System Diseases |
C00001408
|
D009846 | Oliguria |
C00001408
|
D010300 | Parkinson Disease |
C00001408
|
D020734 | Parkinsonian Disorders |
C00001408
|
D010547 | Persistent Fetal Circulation Syndrome |
C00001408
|
D011595 | Psychomotor Agitation |
C00001408
|
D012127 | Respiratory Distress Syndrome, Newborn |
C00001408
|
D012769 | Shock |
C00001408
|
D012770 | Shock, Cardiogenic |
C00001408
|
D012772 | Shock, Septic |
C00001408
|
D013226 | Status Epilepticus |
C00001408
|
D013375 | Substance Withdrawal Syndrome |
C00001408
|
D001480 | Basal Ganglia Diseases |
C00001408
|
D013616 | Tachycardia, Sinus |
C00001408
|
D016171 | Torsades de Pointes |
C00001408
|
D020301 | Vasospasm, Intracranial |
C00001408
|
D002493 | Central Nervous System Diseases |
C00001408
|
D001145 | Arrhythmias, Cardiac |
C00001408
|
D000788 | Angina Pectoris, Variant |
C00001408
|
D011230 | Precancerous Conditions |
C00001428
|
D058186 | Acute Kidney Injury |
C00001408
|
D019969 | Amphetamine-Related Disorders |
C00001151
|
D018149 | Glucose Intolerance |
C00001151
|
D006461 | Hemolysis |
C00001151
|
D006946 | Hyperinsulinism |
C00001151
|
D007333 | Insulin Resistance |
C00001151
|
D009401 | Nephrosis |
C00001151
|
C541083 | Non-alcoholic Fatty Liver Disease |
C00001151
|
D019966 | Substance-Related Disorders |
C00001151
|
D009202 | Cardiomyopathies |
C00001435
|
D002543 | Cerebral Hemorrhage |
C00001435
|
D002637 | Chest Pain |
C00001435
|
D008881 | Migraine Disorders |
C00001435
|
D015878 | Mydriasis |
C00001435
|